{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:28:50Z","timestamp":1783045730781,"version":"3.54.6"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,9,13]],"date-time":"2007-09-13T00:00:00Z","timestamp":1189641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,13]],"date-time":"2007-09-13T00:00:00Z","timestamp":1189641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.ijir.3901610","type":"journal-article","created":{"date-parts":[[2007,9,13]],"date-time":"2007-09-13T11:19:26Z","timestamp":1189682366000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u2018Off-label\u2019 drug use in sexual medicine treatment"],"prefix":"10.1038","volume":"20","author":[{"given":"B","family":"Fallon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,13]]},"reference":[{"key":"BF3901610_CR1","unstructured":"US Food and Drug Administration. \u2018Off-label\u2019 and investigational use of marketed drugs, biologics, and medical devices. http:\/\/www.fda.gov\/oc\/ohrt\/irbs\/offlabel.html."},{"key":"BF3901610_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","volume":"166","author":"DC Radley","year":"2006","unstructured":"Radley DC, Finkelstein SN, Stafford RS . Off-label prescribing among office-based physicians. Arch Intern Med 2006; 166: 1021\u20131026.","journal-title":"Arch Intern Med"},{"key":"BF3901610_CR3","first-page":"63","volume":"90","author":"AG Dooley","year":"2007","unstructured":"Dooley AG . Off-label drug use. Med Health RI 2007; 90: 63\u201365.","journal-title":"Med Health RI"},{"key":"BF3901610_CR4","unstructured":"Plaza CI . Health insurance oversight issue brief; mandated benefits: off-label drug coverage requirements: (year end report\u20142004). Issue Brief Health Policy Track Serv 2004; 1\u20139."},{"key":"BF3901610_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/01947649909511094","volume":"20","author":"V Henry","year":"1999","unstructured":"Henry V . Off-label prescribing: legal implications. J Leg Med 1999; 20: 365\u2013384.","journal-title":"J Leg Med"},{"key":"BF3901610_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0166-4328(97)00183-6","volume":"92","author":"MD Waldinger","year":"1998","unstructured":"Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G . Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111\u2013118.","journal-title":"Behav Brain Res"},{"key":"BF3901610_CR7","doi-asserted-by":"crossref","unstructured":"Waldinger MD, Hengeveld MW, Zwinderman AH . Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994; 1377\u20131379.","DOI":"10.1176\/ajp.151.9.1377"},{"key":"BF3901610_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.ijir.3901172","volume":"16","author":"MD Waldinger","year":"2004","unstructured":"Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B . Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004; 16: 369\u2013381.","journal-title":"Int J Impot Res"},{"key":"BF3901610_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11255-006-6659-2","volume":"39","author":"Z Athanasios","year":"2007","unstructured":"Athanasios Z, Polyanthi P, George K . The efficacy of duloxetine in the treatment of premature ejaculation. Int Urol Nephrol 2007; 39: 115\u2013118.","journal-title":"Int Urol Nephrol"},{"key":"BF3901610_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/sj.ijir.3901469","volume":"18","author":"M Arafa","year":"2006","unstructured":"Arafa M, Shamloul R . Efficacy of sertraline hydrochloride in treatment of premature ejaculation: a placebo-controlled study using a validated questionnaire. Int J Impot Res 2006; 18: 534\u2013538.","journal-title":"Int J Impot Res"},{"key":"BF3901610_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","volume":"368","author":"JL Pryor","year":"2006","unstructured":"Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R . et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006; 368: 929\u2013937.","journal-title":"Lancet"},{"key":"BF3901610_CR12","unstructured":"Shabsigh R, Pryor J, Tesfaye F . Dapoxetine for the treatment of premature ejaculation: low incidence of sexual side effects. Abstract P-05-041 9th Congress of the European Society of Sexual Medicine 2006."},{"key":"BF3901610_CR13","doi-asserted-by":"crossref","unstructured":"Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA . Tramadol HCl has promise in on-demand use to treat premature ejaculation. J Sex Med 2007; e-pub ahead of print: 14 March 2007.","DOI":"10.1016\/S0022-5347(18)31271-0"},{"key":"BF3901610_CR14","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1464-410X.2003.04773.x","volume":"93","author":"W Busato","year":"2004","unstructured":"Busato W, Galindo CC . Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int 2004; 93: 1018\u20131021.","journal-title":"BJU Int"},{"key":"BF3901610_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1464-410X.2006.06583.x","volume":"99","author":"WW Dinsmore","year":"2006","unstructured":"Dinsmore WW, Hackett G, Goldmeier D, Waldinger M, Dean J, Wright P et al. Topical eutectic mixture for premature ejaculation (tempe): a novel aerosol-delivery form of lidocaine\u2013prilocaine for treating premature ejaculation. BJU Int 2006; 99: 369\u2013375.","journal-title":"BJU Int"},{"key":"BF3901610_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.urology.2005.09.002","volume":"67","author":"A Atan","year":"2006","unstructured":"Atan A, Basar MM, Tuncel A, Ferhat M, Agras K, Tekdogan U . Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA- cream- only in treatment of premature ejaculation. Urology 2006; 67: 388\u2013391.","journal-title":"Urology"},{"key":"BF3901610_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/sj.ijir.3900630","volume":"13","author":"IA Abdel-Hamid","year":"2001","unstructured":"Abdel-Hamid IA, El Naggar EA, El Gilany A-H . Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001; 13: 41\u201345.","journal-title":"Int J Impot Res"},{"key":"BF3901610_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","volume":"2","author":"CG McMahon","year":"2005","unstructured":"McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker S, Haughie S et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005; 2: 368\u2013375.","journal-title":"J Sex Med"},{"key":"BF3901610_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","volume":"98","author":"CG McMahon","year":"2006","unstructured":"McMahon CG, McMahon CN, Leow LJ, Winestock CG . Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int 2006; 98: 259\u2013272.","journal-title":"BJU Int"},{"key":"BF3901610_CR20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","volume":"144","author":"MK Gelbard","year":"1990","unstructured":"Gelbard MK, Dorey F, James K . The natural history of Peyronie's disease. J Urol 1990; 144: 1376\u20131379.","journal-title":"J Urol"},{"key":"BF3901610_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","volume":"47","author":"W Weidner","year":"2005","unstructured":"Weidner W, Hauck EW, Schnitker J . Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. Eur Urol 2005; 47: 530\u2013535.","journal-title":"Eur Urol"},{"key":"BF3901610_CR22","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/S0022-5347(05)64173-0","volume":"168","author":"DJ Martin","year":"2002","unstructured":"Martin DJ, Badwan K, Parker M, Mulhall JP . Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol 2002; 168: 2483\u20132485.","journal-title":"J Urol"},{"key":"BF3901610_CR23","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1097\/01.ju.0000056153.47716.d0","volume":"169","author":"LA Levine","year":"2003","unstructured":"Levine LA, Estrada CR, Shou W, Cole A . Tunica albuginea tissue analysis after electromotive drug administration. J Urol 2003; 169: 1775\u20131778.","journal-title":"J Urol"},{"key":"BF3901610_CR24","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.ju.0000116450.82816.2c","volume":"171","author":"SM Di Stasi","year":"2004","unstructured":"Di Stasi SM, Giannantoni A, Stephen RL, Capelli G, Giuriolo A, Jannini EA et al. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. J Urol 2004; 171: 1605\u20131608.","journal-title":"J Urol"},{"key":"BF3901610_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1743-6109.2006.00417.x","volume":"4","author":"WP Fitch III","year":"2007","unstructured":"Fitch III WP, Easterling WJ, Talbert RL, Bordovsky MJ, Mosier M . Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie' disease- a placebo-controlled pilot study. J Sex Med 2007; 4: 477\u2013484.","journal-title":"J Sex Med"},{"key":"BF3901610_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/003655900455422","volume":"34","author":"A Lamprakopoulos","year":"2000","unstructured":"Lamprakopoulos A, Zorzos I, Lykourinas M . The use of betamethasone and hyaluronidase injections in the treatment of Peyronie's disease. Scand J Urol Nephrol 2000; 34: 355\u2013360.","journal-title":"Scand J Urol Nephrol"},{"key":"BF3901610_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","volume":"149","author":"MK Gelbard","year":"1993","unstructured":"Gelbard MK, James K, Riach P, Dorey F . Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol 1993; 149: 56\u201358.","journal-title":"J Urol"},{"key":"BF3901610_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/00365599109024539","volume":"25","author":"MR Duncan","year":"1991","unstructured":"Duncan MR, Berman B, Nseyo UO . Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol 1991; 25: 89\u201394.","journal-title":"Scand J Urol Nephrol"},{"key":"BF3901610_CR29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000480857","volume":"32","author":"HE Wegner","year":"1997","unstructured":"Wegner HE, Andresen R, Knispel HH, Miller K . Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease. Eur Urol 1997; 32: 190\u2013193.","journal-title":"Eur Urol"},{"key":"BF3901610_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1464-410X.1997.02849.x","volume":"79","author":"IS Judge","year":"1997","unstructured":"Judge IS, Wisniewski ZS . Intralesional interferon in the treatment of Peyronie's disease: a pilot study. Br J Urol 1997; 79: 40\u201342.","journal-title":"Br J Urol"},{"key":"BF3901610_CR31","unstructured":"Inal T, Tokatli Z, Akand M, Ozdiler E, Yaman O . Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study."},{"key":"BF3901610_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","volume":"176","author":"WJ Hellstrom","year":"2006","unstructured":"Hellstrom WJ, Kendirci M, Matern R, Cockerham Y, Myers L, Sikka SC et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon \u03b1-2b for minimally invasive treatment for Peyronie's disease. J Urol 2006; 176: 394\u2013398.","journal-title":"J Urol"},{"key":"BF3901610_CR33","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","volume":"151","author":"LA Levine","year":"1994","unstructured":"Levine LA, Merrick PF, Lee RC . Intralesional verapamil injection for the treatment of Peyronie's disease. J Urol 1994; 151: 1522\u20131524.","journal-title":"J Urol"},{"key":"BF3901610_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","volume":"168","author":"LA Levine","year":"2002","unstructured":"Levine LA, Goldman KE, Greenfield JM . Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol 2002; 168: 621\u2013625.","journal-title":"J Urol"},{"key":"BF3901610_CR35","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","volume":"51","author":"J Rehman","year":"1998","unstructured":"Rehman J, Benet A, Melman A . Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology 1998; 51: 620\u2013626.","journal-title":"Urology"},{"issue":"6","key":"BF3901610_CR36","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","volume":"69","author":"Nelson E. Bennett","year":"2007","unstructured":"Bennett NE, Guhring P, Mulhall JP . Intralesional verapamil prevents the progression of Peyronie's disease. Urology 2007; 1181\u20131184.","journal-title":"Urology"},{"key":"BF3901610_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.eururo.2006.10.042","volume":"51","author":"S Russell","year":"2007","unstructured":"Russell S, Steers W, McVary KT . Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease. Eur Urol 2007; 51: 601\u2013603.","journal-title":"Eur Urol"},{"key":"BF3901610_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jama.281.6.537","volume":"281","author":"EO Laumann","year":"1999","unstructured":"Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537\u2013544.","journal-title":"JAMA"},{"key":"BF3901610_CR39","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0022-5347(05)67828-7","volume":"163","author":"R Basson","year":"2000","unstructured":"Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888\u2013893.","journal-title":"J Urol"},{"key":"BF3901610_CR40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0015-0282(02)02969-2","volume":"77","author":"G Bachmann","year":"2002","unstructured":"Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002; 77: 660\u2013665.","journal-title":"Fertil Steril"},{"key":"BF3901610_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.ijir.3901178","volume":"16","author":"A Guay","year":"2004","unstructured":"Guay A, Munarriz R, Jacobson J, Talakoub L, Traish A, Quirk F et al. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20\u201349 years with no complaints of sexual dysfunction. Int J Impot Res 2004; 16: 112\u2013120.","journal-title":"Int J Impot Res"},{"key":"BF3901610_CR42","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1210\/jc.2005-0212","volume":"90","author":"SL Davison","year":"2005","unstructured":"Davison SL, Bell R, Donath S, Montalto JG, Davis SR . Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90: 3847\u20133853.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF3901610_CR43","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0015-0282(03)00358-3","volume":"79","author":"RA Lobo","year":"2003","unstructured":"Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG . Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003; 79: 1341\u20131352.","journal-title":"Fertil Steril"},{"key":"BF3901610_CR44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1056\/NEJM200009073431002","volume":"343","author":"JL Shifren","year":"2000","unstructured":"Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Eng J Med 2000; 343: 682\u2013688.","journal-title":"N Eng J Med"},{"key":"BF3901610_CR45","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","volume":"165","author":"GD Braunstein","year":"2005","unstructured":"Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005; 165: 1582\u20131589.","journal-title":"Arch Intern Med"},{"key":"BF3901610_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.gme.0000179049.08371.c7","volume":"13","author":"SR Davis","year":"2006","unstructured":"Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 2006; 13: 387\u2013396.","journal-title":"Menopause"},{"key":"BF3901610_CR47","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1210\/jc.2006-1121","volume":"91","author":"ME Wierman","year":"2006","unstructured":"Wierman ME, Basson R, Davis SR, Khosia S, Miller KK, Rosner W et al. Androgen therapy in women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 3697\u20133710.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3901610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3901610","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3901610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:20:45Z","timestamp":1648675245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3901610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,13]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF3901610"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijir.3901610","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,13]]},"assertion":[{"value":"11 July 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}